ASMB has been in the news 375% more than usual
Sep 18, 2025, 4:32 PM
38.42%
What does ASMB do
Assembly Biosciences, a biotechnology company based in South San Francisco, develops treatments for chronic hepatitis B and other infectious diseases, with a pipeline including multiple antiviral agents. The company, which went public in December 2010, employs 65 people.
ASMB has been in the news recently: Kevin Offel has been appointed CEO of Assembly Health, effective September 4, with the goal of promoting growth and success in the healthcare sector. Assembly Health is a relevant entity within the broader context of Assembly Biosciences, focusing on advancements in healthcare solutions.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.